Page last updated: 2024-08-17

uridine triphosphate and Acute Disease

uridine triphosphate has been researched along with Acute Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Belosludtseva, NV; Bulion, VV; Evdokimova, NR; Krylova, IB; Mironova, GD; Rodionova, OM; Selina, EN; Shigaeva, MI	1
Bendavit, GG; Cohen, JC; Geller, M; Higashi, R; Mibielli, MA; Nunes, CP; Oliveira, L; Scussel, AB	1
Fatkullin, IF; Vafina, ZR; Ziganshin, AU	1

Trials

1 trial(s) available for uridine triphosphate and Acute Disease

Article	Year
Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin. Proceedings of the Western Pharmacology Society, 2010, Volume: 53 Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monophosphate; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Pain; Uridine Triphosphate	2010

Article

Year

Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin.

Proceedings of the Western Pharmacology Society, 2010, Volume: 53

Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monophosphate; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Pain; Uridine Triphosphate

2010

Other Studies

2 other study(ies) available for uridine triphosphate and Acute Disease

Article	Year
Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel. Scientific reports, 2021, 08-20, Volume: 11, Issue:1 Topics: Acute Disease; Adenosine Triphosphate; Animals; Antioxidants; Arrhythmias, Cardiac; Disease Models, Animal; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Rats, Wistar; Tachycardia; Uridine; Uridine Diphosphate; Uridine Triphosphate; Ventricular Fibrillation	2021
Contrasting effects of P2 receptor agonists on spontaneous contractility of human fallopian tubes with and without acute inflammation. Pharmacological research, 2008, Volume: 57, Issue:1 Topics: Acute Disease; Adenosine Triphosphate; Dose-Response Relationship, Drug; Fallopian Tubes; Female; Humans; In Vitro Techniques; Muscle Contraction; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Salpingitis; Uridine Triphosphate	2008

Article

Year

Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel.

Scientific reports, 2021, 08-20, Volume: 11, Issue:1

Topics: Acute Disease; Adenosine Triphosphate; Animals; Antioxidants; Arrhythmias, Cardiac; Disease Models, Animal; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Rats, Wistar; Tachycardia; Uridine; Uridine Diphosphate; Uridine Triphosphate; Ventricular Fibrillation

2021

Contrasting effects of P2 receptor agonists on spontaneous contractility of human fallopian tubes with and without acute inflammation.

Pharmacological research, 2008, Volume: 57, Issue:1

Topics: Acute Disease; Adenosine Triphosphate; Dose-Response Relationship, Drug; Fallopian Tubes; Female; Humans; In Vitro Techniques; Muscle Contraction; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Salpingitis; Uridine Triphosphate

2008